Your browser doesn't support javascript.
loading
The effects of pomegranate consumption on blood pressure in adults: A systematic review and meta-analysis.
Bahari, Hossein; Omidian, Kosar; Goudarzi, Kian; Rafiei, Hossein; Asbaghi, Omid; Hosseini Kolbadi, Kosar Sadat; Naderian, Moslem; Hosseini, Ali.
Afiliação
  • Bahari H; Transplant Research Center, Clinical Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Omidian K; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Goudarzi K; Faculty of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • Rafiei H; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Asbaghi O; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hosseini Kolbadi KS; Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Naderian M; Faculty of Medicine, Iran University of Medical Science, Tehran, Iran.
  • Hosseini A; Department of Pharmacognosy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Phytother Res ; 38(5): 2234-2248, 2024 May.
Article em En | MEDLINE | ID: mdl-38410857
ABSTRACT
Considering the main component of cardiovascular disease and due to the high prevalence of hypertension, controlling blood pressure is required in individuals with various health conditions. Randomized clinical trials (RCTs) which studied the effects of pomegranate consumption on blood pressure have shown inconsistent findings. As a result, we intended to assess the effects of pomegranate consumption on systolic (SBP) and diastolic (DBP) blood pressure in adults. Systematic literature searches up to January 2024 were carried out using electronic databases, including PubMed, Web of Science, and Scopus, to identify eligible RCTs assessing the effects of pomegranate on blood pressure as an outcome. All the individuals who took part in our research were adults who consumed pomegranate in different forms as part of the study intervention. Heterogeneity tests of the selected trials were performed using the I2 statistic. Random effects models were assessed based on the heterogeneity tests, and pooled data were determined as the weighted mean difference (WMD) with a 95% confidence interval (CI). Of 2315 records, 22 eligible RCTs were included in the current study. Our meta-analysis of the pooled findings showed that pomegranate consumption significantly reduced SBP (WMD -7.87 mmHg; 95% CI -10.34 to -5.39; p < 0.001) and DBP (WMD -3.23 mmHg; 95% CI -5.37 to -1.09; p = 0.003). Individuals with baseline SBP > 130 mmHg had a significantly greater reduction in SBP compared to individuals with baseline SBP < 130 mmHg. Also, there was a high level of heterogeneity among studies (SBP I2 = 90.0% and DBP I2 = 91.8%). Overall, the results demonstrated that pomegranate consumption lowered SBP and DBP in adults. Although our results suggest that pomegranate juice may be effective in reducing blood pressure in the pooled data, further high-quality studies are needed to demonstrate the clinical efficacy of pomegranate consumption.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pressão Sanguínea / Punica granatum / Hipertensão Limite: Adult / Humans Idioma: En Revista: Phytother Res Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pressão Sanguínea / Punica granatum / Hipertensão Limite: Adult / Humans Idioma: En Revista: Phytother Res Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã